191 related articles for article (PubMed ID: 33038796)
1. Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation.
Pecnard S; Provot O; Levaique H; Bignon J; Askenatzis L; Saller F; Borgel D; Michallet S; Laisne MC; Lafanechère L; Alami M; Hamze A
Eur J Med Chem; 2021 Jan; 209():112873. PubMed ID: 33038796
[TBL] [Abstract][Full Text] [Related]
2. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
Naret T; Bignon J; Bernadat G; Benchekroun M; Levaique H; Lenoir C; Dubois J; Pruvost A; Saller F; Borgel D; Manoury B; Leblais V; Darrigrand R; Apcher S; Brion JD; Schmitt E; Leroux FR; Alami M; Hamze A
Eur J Med Chem; 2018 Jan; 143():473-490. PubMed ID: 29202409
[TBL] [Abstract][Full Text] [Related]
3. Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues.
Pecnard S; Hamze A; Bignon J; Prost B; Deroussent A; Gallego-Yerga L; Peláez R; Paik JY; Diederich M; Alami M; Provot O
Eur J Med Chem; 2021 Nov; 223():113656. PubMed ID: 34171660
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
5. A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors.
Barnes NG; Parker AW; Ahmed Mal Ullah AA; Ragazzon PA; Hadfield JA
Bioorg Med Chem; 2020 Oct; 28(19):115684. PubMed ID: 32912434
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
7. Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study.
Mustafa M; Anwar S; Elgamal F; Ahmed ER; Aly OM
Eur J Med Chem; 2019 Dec; 183():111697. PubMed ID: 31536891
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
[TBL] [Abstract][Full Text] [Related]
9. Novel Combretastatin A-4 Analogs-Design, Synthesis, and Antiproliferative and Anti-Tubulin Activity.
Jędrzejczyk M; Morabito B; Żyżyńska-Granica B; Struga M; Janczak J; Aminpour M; Tuszynski JA; Huczyński A
Molecules; 2024 May; 29(10):. PubMed ID: 38792062
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.
Duan YT; Man RJ; Tang DJ; Yao YF; Tao XX; Yu C; Liang XY; Makawana JA; Zou MJ; Wang ZC; Zhu HL
Sci Rep; 2016 May; 6():25387. PubMed ID: 27138035
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.
Aziz J; Brachet E; Hamze A; Peyrat JF; Bernadat G; Morvan E; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Tueni M; Yassine A; Brion JD; Alami M
Org Biomol Chem; 2013 Jan; 11(3):430-42. PubMed ID: 23047722
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; Neamatallah T; Abdel-Samii ZK; Safo MK; Elshaier YAMM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):802-818. PubMed ID: 33730937
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents.
Pang Y; An B; Lou L; Zhang J; Yan J; Huang L; Li X; Yin S
J Med Chem; 2017 Sep; 60(17):7300-7314. PubMed ID: 28792756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
